bpc 157 local injection BPC-157 Injectable Peptide for Healing & Recovery BPC-157 10mg Vial - Mesilla
Description
Results from an innovative proof-of-concept pilot study support this concept (154)
In a randomized, double-blind, placebo-controlled trial published in The Lancet, obese patients receiving Tesofensine experienced substantially greater weight reductions compared to those on a placebo
This product is not covered by insurance
Low risk, minimal downtime and more affordable than surgery
This burning typically worsens after meals, when lying down, or when bending over
Final conclusion: IV infusion: dilute in 5% dextrose stable and chloride-free
